Author:
Zhang Wei,Zhang Jian,Kang Yansheng,Liu Jingjing,Wang Xiaoqing,Xu Qingbin,Wang Yilei,Xu Xiaoya,Dai Guidong
Funder
Ministry of Education of the People׳s Republic of China
National Natural Science Foundation of China
Reference27 articles.
1. Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality;Böger;Clin. Chem. Lab Med.,2005
2. Pharmacological research progress of oxymatrine on cardiovascular and cerebral diseases;Chen;Chin. J. New Drugs Clin. Rem.,2012
3. Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats;De Gennaro Colonna;Eur. J. Pharmacol.,2007
4. Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule;De Gennaro Colonna;Med. Sci. Monit.,2009
5. Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure;Dückelmann;Arterioscler. Thromb. Vasc. Biol.,2007
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献